检索

标题
作者
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G., Lopatin Y., Ametov A., Ageev F., Antsiferov M., Villevalde S., Vinogradova N., Galstyan G., Galyavich A., Gilyarevskiy S., Glezer M., Zhirov I., Ilyin M., Lebedeva A., Nedogoda S., Salukhov V., Tarlovskaya E., Tereshchenko S., Fomin I., Khalimov I., Khasanov N., Cherkashin D., Yakushin S.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F., Remizov O., Goloeva V., Ikoeva Z.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Fomin V.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M., Kotovskaya Y., Ivashkin V., Tkacheva O., Troshina E., Shestakova M., Breder V., Geyvandova N., Doshchitsin V., Dudinskaya E., Ershova E., Kodzoeva K., Komshilova K., Korochanskaya N., Mayorov A., Mishina E., Nadinskaya M., Nikitin I., Pogosova N., Tarzimanova A., Shamkhalova M.
Frailty and chronic kidney disease – the real problem of modern nephrology: A review
Rudenko T., Bobkova I., Kamyshova E., Stavrovskaya E.
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
Murkamilov I., Aitbaev K., Fomin V.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F., Remizov O., Botcieva V., Goloeva V., Malakhova N., Ikoeva Z.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E., Dudnikova A.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N., Moiseev S.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L., Taranova M., Volkov A., Milovanova S., Beketov V.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M., Frolova N., Kim I., Ushakova A., Usatiuk S., Iskhakov R., Diakova E., Chervinko V., Volodina E., Tomilina N., Kryukov E.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O., Orlova A., Rogozhkina E., Drapkina O.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V., Pulin A., Mukhin N.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G., Tarlovskaia E., Koziolova N., Boldina M., Batiushin M., Ametov A., Arutiunov A., Belevskii A., Galstian G., Grigor’eva N., Dzhunusbekova G., Esaian A., Mal’chikova S., Mit’kovskaia N., Mkrtumian A., Orlova I., Petrova M., Rebrov A., Ruzanov D., Salukhov V., Sisakian A., Skibitskii V., Sugraliev A., Fomin I., Khalimov I., Chesnikova A., Shaposhnik I., Shestakova M.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V., Kalaeva V., Evseeva M., Gruzdeva O., Zykov M., Kashtalap V., Barbarash O.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S., Karovaikina E., Bulanov N., Moiseev A., Fomin V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E., Dmitriev V., Titov V.
Motivation for treatment in patients with chronic cardiorenal syndrome
Efremova E., Shutov A., Borodulina E.
Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia
Kaliuzhin V., Sibireva O., Urazova O., Tkalich L., Zibnitskaia L., Kaliuzhina E., Sazonov É., Grankina V.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I., Stavrovskaia E.
New markers of cardio-renal links in chronic kidney disease
Milovanova L., Milovanov I., Kozlovskaia L., Mukhin N.
PERSONIFICATED MEDICINE IN CLINICAL NEPHROLOGY
Mukhin N., Fomin V.
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
Milovanova L., Milovanov Y., Kudryavtseva D., Markina M., Milovanova S., Kozlovskaya L., Lebedeva M., Beketov V., Moiseev S., Mukhin N., Fomin V., Svistunov A.
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease
Mikhailova N.
Diabetes epidemiology in Russia: what has changed over the decade?
Shestakova M., Vikulova O., Zheleznyakova A., Isakov M., Dedov I.
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease
Milovanova L., Dobrosmyslov I., Milovanov I.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study
Batyushin M.
Nutritional support for patients with chronic kidney disease at pre-dialysis stages
Kuzmina A.
Glycemic control in patients with diabetes mellitus on hemodialysis
Lobanova K., Severina A., Martinov S., Shamkhalova M., Shestakova M.
Normoalbuminuric chronic kidney disease in diabetes
Klimontov V., Korbut A.
Acute glomerulonephritis in the 21st century
Mukhin N., Glybochko P., Svistunov A., Fomin V., Shilov E., Lysenko L.
THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
Kutyrina I., Kryachkova A., Savelieva S.
Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies
Saganova E., Zubina I., Bogdanova E., Galkina O., Sipovskii V., Smirnov A.
Circulating microRNAs as potential biomarkers of chronic kidney disease
Aitbaev K., Murkamilov I., Fomin V.
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V., Klimontov V., Myakina N., Tyan N., Fazullina O., Romanov V.
Hyperuricemia and the problem of chronic kidney disease
Shcherbak A., Kozlovskaia L., Bobkova I., Balkarov I., Lebedeva M., Stakhova T.
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity
Galliamov M., Saginova E., Severova M., Samokhodskaia L., Krasnova T., Sholomova V., Sorokin I., Mukhin N.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.
Chronic kidney disease as a multidisciplinary problem of contemporary medicine
Podzolkov V., Bragina A.
Cardiorenal prognosis in kidney dysfunction patients undergoing cardiac surgery
Iskenderov B., Sisina O.
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review)
Strizhakov L., Fomin V., Garipova R., Babanov S., Arkhipov E., Lebedeva M.
Specific features of cognitive impairments in patients with predialysis chronic kidney disease
Rogova I., Fomin V., Damulin I., Shashkova E.
Chronic progressive nephropathies and modern lifestyle
Mukhin N., Balkarov I., Moiseev S., Fomin V., Lebedeva M., Krasnova E.
1 - 50 的 50 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##